Target Name: MIR548AY
NCBI ID: G102465247
Review Report on MIR548AY Target / Biomarker Content of Review Report on MIR548AY Target / Biomarker
MIR548AY
Other Name(s): MicroRNA 548ay | microRNA 548ay | microRNA mir-548ay | hsa-miR-548ay-3p | hsa-miR-548ay-5p | hsa-mir-548ay

Discovering a Potential Drug Target and Biomarker for Cancer

MicroRNA 548ay (miRNA 548ay) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. The discovery of miRNA 548ay was made by a team of researchers at the University of California, San Diego, led by Dr. Qin Liu.

miRNA 548ay is a member of the miRNA family, which are small non-coding RNAs that play a critical role in post-transcriptional gene regulation. These molecules are made by RNA polymerases and can be translated into proteins that either promote or inhibit protein synthesis. MiRNA 548ay is unique because of its specific sequence and the fact that it has been shown to have a unique function in the regulation of cellular processes.

One of the key functions of miRNA 548ay is its role in cell signaling. This molecule has been shown to play a role in the regulation of cell proliferation and has been linked to the development and progression of various diseases, including cancer. For example, studies have shown that high levels of miRNA 548ay have been associated with the development of cancer cells, and that inhibiting the activity of this molecule has the potential to be a new cancer therapeutic.

Another function of miRNA 548ay is its role in cellular pathways that involve cell adhesion and migration. This molecule has been shown to play a role in the regulation of cell-cell adhesion and has been linked to the development of various diseases, including cancer. For example, studies have shown that miRNA 548ay is involved in the regulation of tight junction formation, which is a critical step in cell-cell adhesion. Additionally, miRNA 548ay has been shown to be involved in the regulation of cell migration, which is critical for the development of cancer.

In addition to its role in cell signaling and cell adhesion, miRNA 548ay has also been shown to play a role in the regulation of cellular processes that are involved in the development of diseases. For example, studies have shown that miRNA 548ay is involved in the regulation of the immune response, which is critical for the development of many diseases, including cancer. Additionally, miRNA 548ay has been shown to play a role in the regulation of cell apoptosis, which is a natural process that helps to remove damaged or dysfunctional cells from the body.

The potential drug target and biomarker properties of miRNA 548ay make it an attractive target for researchers to study. The discovery of this molecule has the potential to lead to new understandings about the regulation of cellular processes and the development of diseases. Additionally, the potential therapeutic uses of miRNA 548ay make it an important area of research for the development of new treatments for a variety of diseases.

In conclusion, miRNA 548ay is a unique and promising molecule that has the potential to be a drug target and biomarker for a variety of diseases. The discovery of this molecule has the potential to lead to new understandings about the regulation of cellular processes and the development of diseases. Further research is needed to fully understand the functions of miRNA 548ay and its potential therapeutic uses.

Protein Name: MicroRNA 548ay

The "MIR548AY Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR548AY comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR548AZ | MIR548B | MIR548BA | MIR548BC | MIR548C | MIR548D1 | MIR548D2 | MIR548E | MIR548F1 | MIR548F2 | MIR548F3 | MIR548F4 | MIR548F5 | MIR548G | MIR548H1 | MIR548H2 | MIR548H3 | MIR548H4 | MIR548H5 | MIR548I1 | MIR548I2 | MIR548I3 | MIR548I4 | MIR548J | MIR548K | MIR548L | MIR548M | MIR548N | MIR548O | MIR548O2 | MIR548P | MIR548Q | MIR548S | MIR548T | MIR548U | MIR548V | MIR548W | MIR548X | MIR548Y | MIR549A | MIR550A1 | MIR550A2 | MIR550A3 | MIR550B1 | MIR550B2 | MIR551A | MIR551B | MIR552 | MIR553 | MIR554 | MIR555 | MIR556 | MIR557 | MIR5571 | MIR5572 | MIR5579 | MIR558 | MIR5580 | MIR5581 | MIR5582 | MIR5583-1 | MIR5584 | MIR5585 | MIR5586 | MIR5587 | MIR5588 | MIR5589 | MIR559 | MIR5590 | MIR5591 | MIR561 | MIR562 | MIR563 | MIR564 | MIR566 | MIR567 | MIR568 | MIR5680 | MIR5681A | MIR5681B | MIR5682 | MIR5683 | MIR5684 | MIR5685 | MIR5687 | MIR5688 | MIR5689 | MIR569 | MIR5690 | MIR5691 | MIR5692A1 | MIR5692A2 | MIR5692B | MIR5692C1 | MIR5692C2 | MIR5693 | MIR5694 | MIR5695 | MIR5696 | MIR5697